Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02414165
Title P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA (Toca5)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Tocagen Inc.
Indications

glioblastoma

Therapies

Bevacizumab

Lomustine

Toca 511 + Toca FC

Temozolomide

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.